Welcome to our dedicated page for Procter & Gamble SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Procter & Gamble Company filings document material-event reporting for an Ohio-incorporated consumer products issuer with PG common stock listed on the New York Stock Exchange. The company’s recent 8-K records identify its registered common stock and a broad schedule of exchange-listed notes.
Those disclosures cover capital-structure reference points, including U.S. dollar, euro and British pound notes with maturities spanning short- and long-dated issues. The filings also provide recurring public-company identifiers, exchange listings and formal reporting details tied to P&G’s securities.
Procter & Gamble CEO – Grooming Gary A. Coombe reported multiple equity transactions in Procter & Gamble common stock. On February 12, 2026, he exercised stock options for 36,093 shares at an exercise price of $78.52 per share, receiving the same number of common shares.
On the same date, he then sold 36,093 common shares in open-market transactions at a weighted average price of $162.3307, leaving 34,993.7893 shares of directly held common stock. He also reports indirect holdings of 486.4342 shares through a retirement plan trustee and 1,295.35 shares through an international stock ownership and pension plan.
In addition, previously granted restricted stock units, including 63.6893 units awarded on November 17, 2025, total 1,117.3663 RSUs. Footnotes explain that these RSUs and some share totals include dividend equivalents and may be delivered in shares upon retirement under the company’s programs.
The Procter & Gamble Company investor files a notice to sell restricted shares under Rule 144. The planned transaction covers 15,169 shares of common stock with an aggregate market value of $2,448,124.91, to be executed through Morgan Stanley Smith Barney LLC on the NYSE.
The shares were acquired and paid for in cash on 02/13/2026 through an exercise and sale of stock options. The filing also notes that Procter & Gamble had 2,324,000,685 shares of common stock outstanding, providing context for the size of this proposed sale.
An insider of Procter & Gamble plans to sell 12,827 shares of common stock under Rule 144. The planned sale has an aggregate market value of $2,022,176.55 and is scheduled for 02/11/2026 on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services.
The shares will come from the exercise and sale of a stock option, paid in cash on 02/11/2026. The filing notes that Procter & Gamble has 2,324,000,685 common shares outstanding, which provides scale for the size of this planned transaction.
The Procter & Gamble Company has a shareholder filing a notice of proposed sale of 173,268 shares of common stock, with an aggregate market value of $27,315,700.20. The planned sale is tied to the exercise and sale of a stock option on 02/11/2026.
The shares are to be sold for cash through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE. The filing notes total common shares outstanding of 2,324,000,685 and includes a representation that the seller is not aware of undisclosed material adverse information about Procter & Gamble.
A holder of Procter & Gamble common stock has filed a notice of proposed sale under Rule 144. The filer plans to sell 2,215 shares of common stock with an aggregate market value of $352,185.00 and an additional 558 shares valued at $88,722.00. Both transactions are to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE, with an approximate sale date of February 10, 2026. The securities to be sold were originally acquired as restricted stock unit awards from The Procter & Gamble Company on March 1, 2022 and October 3, 2022.
Procter & Gamble executive Ma. Fatima Francisco, CEO of the Baby, Fem & Family Care unit, reported a sale of 8,000 shares of common stock on 02/04/2026 at $158 per share. After this sale, she directly holds 6,571.1998 shares of P&G common stock.
She also reports indirect holdings of 16,139.3909 shares through a retirement plan trustee, 2,898.8166 shares held by her spouse and retirement plan trustees, and 12,731 shares held by a SLAT. A footnote states one position reflects an adjustment to PST through December 31, 2025.
Procter & Gamble executive Ma. Fatima Francisco, CEO of the Baby, Fem & Family Care unit, reported a sale of 8,000 shares of common stock on 02/04/2026 at $158 per share. After this sale, she directly holds 6,571.1998 shares of P&G common stock.
She also reports indirect holdings of 16,139.3909 shares through a retirement plan trustee, 2,898.8166 shares held by her spouse and retirement plan trustees, and 12,731 shares held by a SLAT. A footnote states one position reflects an adjustment to PST through December 31, 2025.
The Procter & Gamble Company shareholder filed a notice to sell 72,186 shares of common stock, with an aggregate market value of $11,007,643.14.
The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE around February 4, 2026, and were acquired that same day by exercising a stock option for cash. Shares outstanding were 2,324,000,685 common shares at the time referenced.
The Procter & Gamble Company shareholder filed a notice to sell 72,186 shares of common stock, with an aggregate market value of $11,007,643.14.
The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE around February 4, 2026, and were acquired that same day by exercising a stock option for cash. Shares outstanding were 2,324,000,685 common shares at the time referenced.
The Procter & Gamble Company has an affiliated holder filing a Rule 144 notice to sell up to 13,549 shares of common stock through Fidelity Brokerage Services on the NYSE, with an approximate sale date of 01/29/2026 and an aggregate market value of $2,015,887.97.
These shares relate to a prior restricted stock unit award of 18,412 common shares acquired on 10/01/2020 from The Procter & Gamble Company, with cash as the form of payment. Shares outstanding were 2,324,000,685 at the time referenced. The seller represents they know no undisclosed material adverse information about the issuer.
Procter & Gamble Chief Brand Officer Marc S. Pritchard reported an option exercise and share sale in Procter & Gamble common stock on January 23, 2026. He exercised a stock option for 95,903 shares at an exercise price of $80.29 per share, then sold 95,903 shares of common stock at a weighted average price of $151.1495 per share, within a price range of $150.36 to $151.60. Following these transactions, he directly owned 182,606.5502 shares of Procter & Gamble common stock, with additional indirect holdings through his daughters, retirement plan trustees, and his wife.
The Procter & Gamble Company reports steady results for the three and six months ended December 31, 2025, with modest sales growth but some margin pressure. For the three-month period, net sales rose to $22.2 billion from $21.9 billion (up about 1%), while net earnings declined to $4.3 billion from $4.7 billion and diluted EPS slipped to $1.78 from $1.88 as gross margin and operating margin narrowed due to unfavorable mix, higher tariffs, product and packaging investments and higher restructuring costs.
Over six months, net sales increased to $44.6 billion from $43.6 billion (2% growth), net earnings rose to $9.1 billion from $8.6 billion (5% growth) and diluted EPS grew 7% to $3.73. Core EPS, which excludes incremental restructuring, was $3.87, up 2%. Operating margin eased to 25.2% as higher restructuring and tariff costs outweighed productivity savings and pricing. Operating cash flow reached $10.4 billion, with adjusted free cash flow of $8.7 billion and adjusted free cash flow productivity of 95%, while the company continued significant restructuring and recorded strong contributions from Beauty, Grooming and Health Care segments.